Positive impact of eculizumab therapy on surgery for Budd- Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria and a longterm history of thrombosis
Paroxysmal nocturnal hemoglobinuria (PNH) is associated with severe end-organ damage and a high risk of thrombosis. Budd- Chiari syndrome, which develops after thrombotic occlusion of major hepatic blood vessels, is relatively common in PNH and has been associated with increased mortality. We report...
Main Authors: | Silvia De-la-Iglesia, Hugo Luzardo, Angelina Lemes, Melissa Torres, Maria Teresa Gómez-Casares, Naylen Cruz, Teresa Molero |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-09-01
|
Series: | Hematology Reports |
Subjects: | |
Online Access: | http://www.pagepress.org/journals/index.php/hr/article/view/6562 |
Similar Items
-
Eculizumab for paroxysmal nocturnal hemoglobinuria: Two cases of successful pregnancy outcomes
by: Jovanka Ilic, et al.
Published: (2024-05-01) -
Coronary Artery By-Pass Grafting in Patient With Paroxysmal Nocturnal Hemoglobinuria (Case Report)
by: A. Amendola, et al.
Published: (2021-04-01) -
Disseminated Gonococcal Infection Associated with Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria: A Case Report and Literature Review
by: Saito M, et al.
Published: (2020-07-01) -
The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors: clinical outcomes and medical encounters from the patient perspective
by: Flore Sicre de Fontbrune, et al.
Published: (2022-12-01) -
Eculizumab before and after allogeneic hematopoietic stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria
by: Hakan Göker, et al.
Published: (2011-08-01)